Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. حسب Michael C. Payne (2664379)

الموضوعات:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). حسب Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). حسب Duc Tran Quang (20564967)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). حسب Mingyue Sun (4638535)

(a) Average absolute percentage relative error (AAPRE), and, (b) Coefficient of determination (R²) of the models. حسب Fahd Saeed Alakbari (10701871)

الموضوعات:

Amplitude for A/L = 0.29. حسب Muhammad Hammad Bucha (21736111)

"…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"

Amplitude for A/L = 0.338. حسب Muhammad Hammad Bucha (21736111)

"…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"

Amplitude for A/L = 0.02. حسب Muhammad Hammad Bucha (21736111)

"…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"

Amplitude for A/L = 0.03. حسب Muhammad Hammad Bucha (21736111)

"…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Logistic regression analysis to predict the efficacy for liver function. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison in baseline variables between efficacy group and non-efficacy group. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Clinical characteristics at baseline and at the end of the study. حسب Naruyoshi Gyoutoku (22537831)

الموضوعات:

Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx حسب Nourhen Agrebi (14151222)

"…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …"

Principal Coordinate Analysis (PCoA) based on (A) Unweighted UniFrac, (B) Weighted UniFrac, (C) Bray-Curtis dissimilarity, and (D) Jaccard similarity. حسب Manal Ali Ahmad (16868808)

الموضوعات:

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. حسب Yongqin Wu (272012)

"…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …"

Association between workability and sociodemographic and occupational characteristics. حسب Sarah A. Bolbol (21702891)

الموضوعات:

Sociodemographic, occupational, workability characteristics among diabetic workers. حسب Sarah A. Bolbol (21702891)

الموضوعات:

Correlation between workability and laboratory findings of diabetic workers. حسب Sarah A. Bolbol (21702891)

الموضوعات: